Erythromycin enol ether
- Level
- Commodity
- Parent
- 51282300
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51282315This classification denotes a macrolide antibiotic with the molecular formula C37H65NO12, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 32B40I7V7B, chemically known as erythromycin, 8,9-didehydro-9-deoxo-6-deoxy-6,9-epoxy-, but more generally known as erythromycin enol ether, which bears US NIH Compound Identifier 6426642. European Medicines Agency schedules erythromycin enol ether or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06605MIG. Most nations, for tariff purposes, schedule erythromycin enol ether under HS 29415000. SMILES: CC[C@@H]1[C@@]([C@@H]([C@H](C2=C(C[C@@](O2)([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)OC)C)O[C@H]4[C@@H]([C@H](C[C@H](O4)C)N(C)C)O)C)C)C)O)(C)O.
Same parent
Under 51282300 · 28Activities that produce or sell this
KBLI · 9Inherited from family 51280000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.